Edwards’ TAVR device in moderate aortic stenosis drew applause from meeting attendees, while Medtronic’s renal denervation ...

CEO Ivan Tornos did not attribute the company’s performance in knees to a broader market slowdown, as competitor Stryker did ...

Philips will pay 288 million euros to settle an investigation related to its recall of millions of sleep and respiratory ...

Patients, providers and medtech firms submitted hundreds of comments to the Food and Drug Administration on how the agency ...

The company notified customers this month that it will discontinue Medline brand beds and associated products and exit the ...

The first-of-its-kind transcatheter device treats paravalvular leak after valve replacement surgery, to spare the patient ...

CEO Kevin Lobo said the slowdown in hip and knee procedures is tied to broader economic concerns. The outgoing CEO also ...

M&A rose, but company valuations declined in the first half of 2026 compared with the year-ago period, according to EY’s ...

In a year where companies are grappling with cyberattacks, inflation and potential tariffs, Farrell, who is also CEO of ...

In July 2015, Abbott agreed to buy Tendyne for $225 million upfront and secured an option to acquire Cephea. Abbott CEO ...

Abbott said it is facing pricing pressure and slower growth ahead of a planned coverage expansion for people with Type 2 ...

The testing service providers hope the legislation, which would reform the CMS’ reimbursement rate-setting process, can cross ...